| 摘要 |
A drug which contains a combination of the active ingredients comprising at least one remedy for hyperlipemia selected from the group consisting of fibrate compounds (phenofibrate, bezafibrate, salts thereof, etc.) and HMG-C oA reductase inhibitors (statin compounds such as pravastatin, atorvastatin, salts thereof, etc.) with an .alpha.-glucosidase inhibitor (voglibose, acarbose, etc.). The content of the .alpha.-glucosidase inhibitor may be fro m 0.001 to 50 parts by weight per 100 parts by weight of the remedy for hyperlipemia. Thus, it is possible to provide a drug having excellent effect s of preventing and/or treating metabolic syndrome, hyperlipemia, diabetes, diabetic complications, etc. with little side effect.
|
